Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia
- 31 October 2006
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 30 (10) , 1235-1239
- https://doi.org/10.1016/j.leukres.2006.02.008
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22)Leukemia, 2005
- AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: Implication in stepwise leukemogenesis and response to GleevecProceedings of the National Academy of Sciences, 2005
- Receptor tyrosine kinases in normal and malignant haematopoiesisBlood Reviews, 2003
- Incidence and prognosis of c‐KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemiasBritish Journal of Haematology, 2003
- c‐kit proto‐oncogene exon 8 in‐frame deletion plus insertion mutations in acute myeloid leukaemiaBritish Journal of Haematology, 1999
- RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-upLeukemia, 1998
- Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS- derived leukemiaBlood, 1993
- FMS mutations in myelodysplastic, leukemic, and normal subjects.Proceedings of the National Academy of Sciences, 1990
- Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.Journal of Clinical Pathology, 1985
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982